14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for CRMD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 6.22 6.50 %
R2 6.03 3.30 %
R1 5.92 1.32 %
Current price: 5.84
Support S1 5.54 -5.08 %
S2 5.43 -7.06 %
S3 5.24 -10.26 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 6.39 9.42 %
Current price 5.84
Support S1 5.38 -7.88%
S2 5.28 -9.59%
S3 4.71 -19.35%

CRMD Predictions History

4 years ago
Texasgirl predicted that CRMD for 2019-06-17 is going $11.35 (56.55%)

Rank:

4 years ago
GoldenNugget predicted that CRMD for 2019-05-07 is going $8.09 (4.53%)

5 years ago
NameNotImportant predicted that CRMD for 2019-05-06 is going $8.08 (1.64%)

5 years ago
GoldenNugget predicted that CRMD for 2019-05-06 is going $7.78 (-2.15%)

5 years ago
JoeStockTrader predicted that CRMD for 2019-02-25 is going $2.47 (30.00%)

Rank:

5 years ago
Mark.Brown.88627 predicted that CRMD for 2019-02-19 is going $2.86 (69.23%)

Rank:

5 years ago
JS predicted that CRMD for 2019-02-15 is going $1.90 (12.43%)

5 years ago
Gp predicted that CRMD for 2019-02-15 is going $1.90 (12.43%)

5 years ago
Andy.Kirkwood.96939 predicted that CRMD for 2019-02-15 is going $1.92 (7.87%)

Rank:

5 years ago
PumpTheseNumbers predicted that CRMD for 2019-02-15 is going $2.53 (42.13%)

Click to get the best stock tips daily for free!

About CorMedix Inc

CorMedix CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical setting... CRMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT